Growth Metrics

Cme (CME) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $158.2 billion.

  • Cme's Total Non-Current Liabilities rose 4541.8% to $158.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $158.2 billion, marking a year-over-year increase of 4541.8%. This contributed to the annual value of $110.2 billion for FY2024, which is 789.75% up from last year.
  • According to the latest figures from Q3 2025, Cme's Total Non-Current Liabilities is $158.2 billion, which was up 4541.8% from $151.4 billion recorded in Q2 2025.
  • Cme's Total Non-Current Liabilities' 5-year high stood at $177.3 billion during Q1 2022, with a 5-year trough of $95.0 billion in Q2 2024.
  • Its 5-year average for Total Non-Current Liabilities is $134.2 billion, with a median of $137.8 billion in 2023.
  • In the last 5 years, Cme's Total Non-Current Liabilities surged by 7325.12% in 2021 and then tumbled by 3529.26% in 2023.
  • Over the past 5 years, Cme's Total Non-Current Liabilities (Quarter) stood at $168.5 billion in 2021, then dropped by 13.07% to $146.5 billion in 2022, then tumbled by 30.25% to $102.2 billion in 2023, then grew by 7.9% to $110.2 billion in 2024, then skyrocketed by 43.53% to $158.2 billion in 2025.
  • Its Total Non-Current Liabilities stands at $158.2 billion for Q3 2025, versus $151.4 billion for Q2 2025 and $130.1 billion for Q1 2025.